GI
DGX icon

GAMMA Investing’s Quest Diagnostics DGX Stock Holding History

GAMMA Investing’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.67M Buy
7,167
+1,872
+35% +$433K 0.06% 267
2026
Q2 		$1.12M Buy
5,295
+1,411
+36% +$277K 0.04% 361
2026
Q1 		$761K Buy
3,884
+394
+11% +$76.6K 0.04% 428
2025
Q4 		$606K Sell
3,490
-21
-0.6% -$3.82K 0.03% 465
2025
Q3 		$669K Buy
3,511
+520
+17% +$92.3K 0.04% 417
2025
Q2 		$537K Buy
2,991
+361
+14% +$62.7K 0.03% 456
2025
Q1 		$445K Buy
2,630
+728
+38% +$120K 0.03% 464
2024
Q4 		$287K Buy
1,902
+594
+45% +$92.4K 0.02% 556
2024
Q3 		$203K Buy
1,308
+445
+52% +$66.5K 0.02% 618
2024
Q2 		$118K Buy
863
+211
+32% +$28.9K 0.02% 691
2024
Q1 		$86.8K Buy
652
+133
+26% +$17.3K 0.02% 717
2023
Q4 		$66.7K Buy
+519
New +$68.2K 0.02% 737

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

GAMMA Investing's DGX Position: Q3 2026 in Review

GAMMA Investing increased its Quest Diagnostics (DGX) stake by 35% in Q3 2026, buying an estimated $433K and bringing the position to 7,167 shares worth $1.67M. The position accounts for 0.06% of the portfolio, ranked #267.

GAMMA Investing first reported a position in DGX in Q4 2023 and has held it in 12 quarters since. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • GAMMA Investing held 7,167 shares of Quest Diagnostics worth $1.67M as of Q3 2026.
  • GAMMA Investing bought 1,872 Quest Diagnostics shares in Q3 2026, an estimated $433K.
  • Quest Diagnostics made up 0.06% of GAMMA Investing's portfolio in Q3 2026, its #267 holding.
  • GAMMA Investing first reported a position in Quest Diagnostics in Q4 2023 and has held it in 12 quarters since.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.